In early July, as the covid-19 pandemic slammed rural America, the president of a small Kansas hospital sat down on a Friday afternoon and wrote the president of the United States to plead for help. āI do not intend to add to your burden,ā said Brian Williams, a retired Army lieutenant colonel and Desert Storm […]
Read MoreNEWS CATEGORY: 340B
Hospitals Lose $3.2 Billion Due To Drug Makersā 340B Restrictions
Drug companiesā restrictions on 340B program discounts have cost covered hospitals and clinics $3.2 billion annually, according to a footnote buried in a recent federal court ruling on drug company lawsuits against HHSā effort to make them give 340B discounts to all pharmacies that 340B hospitals contract with. Since October, three federal courts have issued […]
Read MoreIGās Handling Of 340B Opinion Could Help HRSA In Court
HHS on Wednesday (Sept. 22) asked the HHS Inspector General to investigate six drug companies that restrict 340B discounts to pharmacies with which hospitals contract. The move, which could result in fines, is the Health Resources and Services Administrationās latest gambit to get drug companies to comply with its interpretation of a vague law, this […]
Read MoreSCOTUS To Hear Hospitalsā 340B Reimbursement Cuts Suit
The Supreme Court on Friday (July 2) agreed to hear arguments on hospitalsā lawsuit over cuts to Medicare reimbursement for 340B drugs — but on top of the question that hospitals asked it to look at, the court also wants to hear arguments on whether the issue is one that the judges could review or […]
Read MoreSupreme Court Will Hear Challenge to Medicare Drug Payment Cuts
The Supreme Court agreed Friday to hear a case challenging cuts the Department of Health and Human Services made to Medicare prescription-drug reimbursements for hospitals that serve low-income and underserved communities. The American Hospital Association (AHA) and the Association of American Medical Colleges (AAMC), which filed the petition to the high court with various hospital and health […]
Read MoreJudge Refuses To Dismiss 340B Suit After Advisory Opinion Withdrawal
A federal judge will not dismiss AstraZenecaās case against a 340B advisory opinion involving contract pharmacies, even though HHS withdrew that opinion, because HHS still plans to enforce the policy that was the subject of the withdrawn advisory opinion, according to a memorandum order issued Wednesday (June 30) by the U.S. District Court for the […]
Read More